These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 16386314

  • 1. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL, Takahara M, Nagy N, Klein G, Klein E.
    Immunol Lett; 2006 Apr 15; 104(1-2):83-8. PubMed ID: 16386314
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.
    J Immunol Methods; 2012 Nov 30; 385(1-2):60-70. PubMed ID: 22921685
    [Abstract] [Full Text] [Related]

  • 3. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL, Takahara M, Nagy N, Klein G, Klein E.
    Blood; 2006 Apr 01; 107(7):2928-35. PubMed ID: 16332968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
    Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E.
    Blood; 2011 Jan 06; 117(1):165-74. PubMed ID: 20876453
    [Abstract] [Full Text] [Related]

  • 8. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.
    Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E.
    Int J Cancer; 2005 Mar 01; 113(6):937-45. PubMed ID: 15514968
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.
    J Med Virol; 1998 Jul 01; 55(3):219-26. PubMed ID: 9624610
    [Abstract] [Full Text] [Related]

  • 10. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG.
    Cancer Surv; 1992 Jul 01; 13():53-80. PubMed ID: 1330300
    [Abstract] [Full Text] [Related]

  • 11. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.
    Kis LL, Salamon D, Persson EK, Nagy N, Scheeren FA, Spits H, Klein G, Klein E.
    Proc Natl Acad Sci U S A; 2010 Jan 12; 107(2):872-7. PubMed ID: 20080768
    [Abstract] [Full Text] [Related]

  • 12. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 13. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct 01; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.
    Methods; 1997 Jan 01; 11(1):83-7. PubMed ID: 8990093
    [Abstract] [Full Text] [Related]

  • 15. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T.
    Hokkaido Igaku Zasshi; 1990 Jul 01; 65(4):362-75. PubMed ID: 2172130
    [Abstract] [Full Text] [Related]

  • 16. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR.
    J Cell Physiol; 1993 Mar 01; 154(3):486-95. PubMed ID: 8382208
    [Abstract] [Full Text] [Related]

  • 17. Multiple signal transducers and activators of transcription are induced by EBV LMP-1.
    Zhang L, Hong K, Zhang J, Pagano JS.
    Virology; 2004 May 20; 323(1):141-52. PubMed ID: 15165826
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS.
    J Pathol; 1997 Jun 20; 182(2):151-9. PubMed ID: 9274524
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, Jaffe ES.
    Mod Pathol; 1998 Aug 20; 11(8):754-61. PubMed ID: 9720504
    [Abstract] [Full Text] [Related]

  • 20. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 20; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.